Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptorsAdriano Mollica, Romano Silvestri, Valeria Famiglini et al.|Journal of Enzyme Inhibition and Medicinal Chemistry|2017Cited by 39